IPO Boutique

Castle Biosciences, Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Castle Biosciences, Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Castle Biosciences, Inc.CSTL -
NASDAQ
$14.00-$16.00 $16.00 $20.004 million7/25/2019
SVB Leerink, Baird
Co-Manager(s):
Canaccord Genuity, BTIG
Health Care
Filing(s):

Filed 2019-06-26
Terms Added 2019-07-15



Castle Biosciences, Inc. Quote & Chart - Click for current quote - CSTL

About Castle Biosciences, Inc. (adapted from Castle Biosciences, Inc. prospectus):
They are a commercial-stage dermatological cancer company focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "CSTL" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved